focus
Previous article:
Heart attack and stroke risk calculators need revising
Next article: Listen: Biogen's situation, Wegovy's risks, & biotech insider trading
Next article: Listen: Biogen's situation, Wegovy's risks, & biotech insider trading
hotspot
focus
-
Asahi Kasei to buy Calliditas, picking up kidney disease drug
2025-09-06 04:22 -
EQRx, failed developer of low
2025-09-06 03:29 -
What to expect as Trump is arraigned on his Jan 6. indictment
2025-09-06 02:51 -
What the US credit downgrade means for the economy, your finances
2025-09-06 02:49 -
Beyond aggravation: Constipation is an American epidemic
2025-09-06 02:37 -
EQRx, failed developer of low
2025-09-06 02:21